teva semaglutide WEGOVY(SEMAGLUTIDE)1.7MG FLEXTOUCH,1CT behavior change Novo Nordisk's weight-loss pill wins

Adjusted gross margins sit in the mid-70s, and 3Q25 adjusted EBITDA was $43mm at a 24.9% margin

Melanie Jay, who directs the Comprehensive Program on Obesity at NYUs Langone Medical Center

A liquid is already broken down - it contacts the absorption surface faster and with less degradation in the process

With the right guidance, most missed doses can be handled safely and without long-term impact

For questions about our process, you can reach us at 1-647-576-2076

In a 12-week randomized clinical trial involving 300 obese adults, participants receiving 1 mg daily of AOD-9604 lost an average of 2.6 kg (approximately 5.7 pounds) compared to 0.8 kg (1.8 pounds) in the placebo group